Literature DB >> 9310676

Role of Porphyromonas gingivalis, Prevotella intermedia, and Prevotella nigrescens in extraoral and some odontogenic infections.

J Mättö1, S Asikainen, M L Väisänen, M Rautio, M Saarela, P Summanen, S Finegold, H Jousimies-Somer.   

Abstract

Porphyromonas gingivalis, Prevotella intermedia, and Prevotella nigrescens were isolated from 138 subjects with various infections (intraabdominal, skin and soft-tissue, head and neck, pleuropulmonary, and odontogenic infections and bacteremia). The phenotypic identification of 173 isolates was completed by molecular methods. Arbitrarily primed polymerase chain reaction (AP PCR) analysis was used to determine the genetic similarity of intraindividual P. intermedia/P. nigrescens group isolates recovered from 12 subjects. All 19 P. gingivalis isolates (16 intraabdominal isolates and three odontogenic isolates) hybridized with the P. gingivalis-specific DNA probe. Of the 154 P. intermedia/ P. nigrescens group isolates, 74 were identified as P. intermedia; 78, as P. nigrescens; and 2, as P intermedia/P. nigrescens-like isolates. P. intermedia and P. nigrescens were isolated with equal frequency from patients with all other infections except those with bacteremia, from whom only P. nigrescens isolates were recovered. There were 12 cases in which multiple P. intermedia/ P. nigrescens group isolates were recovered; in nine, only one of the species was isolated, whereas in three, two different species were detected. The intraindividual isolates representing the same species always exhibited identical AP PCR genotypes.

Entities:  

Mesh:

Year:  1997        PMID: 9310676     DOI: 10.1086/516205

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  14 in total

1.  In vitro activity of moxifloxacin against bacteria isolated from odontogenic abscesses.

Authors:  Ingo Sobottka; Georg Cachovan; Enno Stürenburg; M Oliver Ahlers; Rainer Laufs; Ursula Platzer; Dietrich Mack
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

2.  Microbial diversity in saliva of oral squamous cell carcinoma.

Authors:  Smruti Pushalkar; Shrinivasrao P Mane; Xiaojie Ji; Yihong Li; Clive Evans; Oswald R Crasta; Douglas Morse; Robert Meagher; Anup Singh; Deepak Saxena
Journal:  FEMS Immunol Med Microbiol       Date:  2011-02-01

3.  Beta-lactamase production in Prevotella intermedia, Prevotella nigrescens, and Prevotella pallens genotypes and in vitro susceptibilities to selected antimicrobial agents.

Authors:  J Mättö; S Asikainen; M L Väisänen; B Von Troil-Lindén; E Könönen; M Saarela; K Salminen; S M Finegold; H Jousimies-Somer
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

Review 4.  Prevotella diversity, niches and interactions with the human host.

Authors:  Adrian Tett; Edoardo Pasolli; Giulia Masetti; Danilo Ercolini; Nicola Segata
Journal:  Nat Rev Microbiol       Date:  2021-05-28       Impact factor: 60.633

5.  Incidence of Prevotella intermedia and Prevotella nigrescens carriage among family members with subclinical periodontal disease.

Authors:  K Fukui; N Kato; H Kato; K Watanabe; N Tatematsu
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

6.  Antimicrobial susceptibilities of Porphyromonas gingivalis, Prevotella intermedia, and Prevotella nigrescens spp. isolated in Spain.

Authors:  M T Andrés; W O Chung; M C Roberts; J F Fierro
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

7.  Heart failure and oral bacteria: How could be prevented?

Authors:  Ali M Tavana
Journal:  J Cardiovasc Dis Res       Date:  2010-07

8.  Osteomyelitis of the jaw: resistance to clindamycin in patients with prior antibiotics exposure.

Authors:  C Pigrau; B Almirante; D Rodriguez; N Larrosa; S Bescos; G Raspall; A Pahissa
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-09-17       Impact factor: 3.267

9.  Primary infectious costochondritis due to Prevotella nigrescens in an immunocompetent patient: clinical and imaging findings.

Authors:  Françoise Derouane; Michel Lambert; Julien De Greef; Jacques Malghem; Frédéric E Lecouvet
Journal:  Skeletal Radiol       Date:  2019-01-26       Impact factor: 2.199

10.  Evaluation of anti-microbial activity of spore powder of Ganoderma lucidum on clinical isolates of Prevotella intermedia: A pilot study.

Authors:  Ranganath N Nayak; P T Dixitraj; Aarati Nayak; Kishore Bhat
Journal:  Contemp Clin Dent       Date:  2015-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.